Appropriability regime in India has undergone a major change in 2005 legalizing product patent protection. Using empirical data from 50 semi-structured interviews with key players in the Indian pharmaceutical sector, we show that a strong appropriability regime favors outbound innovation but restrains inbound innovation in pharmaceutical innovation. We find three appropriability related issues which act as barriers to inbound open innovation - a) preference by public institution researchers to disseminate research results through publications b) poor infrastructure support and c) patent ownership issues. We find that low patenting trends in public institutions inhibits researchers to engage with firms for research collaborations and gives rise to paradox of disclosure. In contrast, the proclivity of firms to appropriate and enhance commercial potential for outbound innovation rather than engage in inbound sourcing of knowledge, for secrecy purposes, leads to paradox of openness. These two paradoxes inhibit open innovation between science and the industry.
|Publication status||Published - 7 Sep 2016|
|Event||BAM 2016: 30th Annual Conference of the British Academy of Management - Newcastle University, Newcastle upon Tyne, United Kingdom|
Duration: 6 Sep 2016 → 8 Sep 2016
|Abbreviated title||BAM 2016|
|City||Newcastle upon Tyne|
|Period||6/09/16 → 8/09/16|
- open Innovation
- patent analysis
- pharmaceutical sector
- outbound innovation
- inbound innovation
- patent ownership
Bhatnagar, B., Dörfler, V., & MacBryde, J. (2016). Dynamics of appropriability regime and open innovation in the Indian pharmaceutical sector: an exploratory analysis. Paper presented at BAM 2016, Newcastle upon Tyne, United Kingdom.